Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(727/week)
    • Manufacturing(378/week)
    • Energy(313/week)
    • Technology(699/week)
    • Other Manufacturing(245/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Pyridines

Jun 17, 2020
Kangpu to Present Two Posters at the 2020 American Association for Cancer Research (AACR) Annual Meeting
Jun 16, 2020
Verzenio® (abemaciclib) Significantly Reduced the Risk of Cancer Returning in People with High Risk HR+, HER2- Early Breast Cancer
Jun 15, 2020
Global Prostate Cancer Market Analysis to 2028 - Prostate Cancer Market Expected to Increase Despite Generic Abiraterone Entry
May 18, 2020
PANTHERx® Rare Pharmacy Selected by Deciphera Pharmaceuticals to Distribute QINLOCK(TM) (ripretinib), for Gastrointestinal Stromal Tumor (GIST) Patients
May 13, 2020
ERLEADA® (apalutamide) Significantly Improved Overall Survival in Patients with Non-Metastatic Castration-Resistant Prostate Cancer
May 08, 2020
Daewoong Pharmaceutical Unveils Phase 3 Clinical Data of Fexuprazan, A Novel Potassium-competitive Acid Blocker
May 07, 2020
Syndax Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Business Update
May 07, 2020
Ascentage Pharma's Core Drug Candidate HQP1351 Granted Fast Track Designation by the US FDA, Marking Another Milestone in Its Development
May 06, 2020
Vanda Pharmaceuticals Reports First Quarter 2020 Financial Results
May 05, 2020
Akebia Announced Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis; Reports First Quarter 2020 Financial Results
May 04, 2020
Ascentage Pharma's Core Drug Candidate HQP1351 Granted Orphan Drug Designation by the US FDA for the Treatment of Patients with Chronic Myeloid Leukemia
Apr 28, 2020
Blueprint Medicines Announces Top-line Results from Phase 3 VOYAGER Trial of Avapritinib versus Regorafenib in Patients with Advanced Gastrointestinal Stromal Tumor
Apr 16, 2020
Cinclus Pharma Appoints Jenni Björnulfson as Chief Financial Officer
Apr 08, 2020
Vanda Pharmaceuticals Inc. And The University of Illinois at Chicago Announce Partnership To Identify Novel Antivirals Against COVID-19
Apr 08, 2020
Trovagene to Present at the 19th Annual Needham Healthcare Conference
Apr 02, 2020
Vanda Pharmaceuticals Announces the Initiation of ODYSSEY, an FDA Approved Clinical Study of Tradipitant in Hospitalized Patients with Severe COVID-19 Pneumonia
Mar 27, 2020
Cipla Receives Final Approval for Generic Version of AstraZeneca Pharmaceutical's Nexium® (Esomeprazole for Oral Suspension 10mg, 20mg and 40mg)
Mar 23, 2020
Akebia Therapeutics to Present Research at NKF 2020 Spring Clinical Meetings Live Virtual Conference
Feb 25, 2020
Vanda Reports results from the EPIONE study of Tradipitant in the treatment of Pruritus in Atopic Dermatitis
Feb 25, 2020
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
  •  
  • Page 1
  • ››

Latest News

Jul 8, 2025

Mitsubishi Electric Named to CDP Supplier Engagement Assessment Leaderboard

Jul 8, 2025

Tigo Energy Adds Solar-Plus-Storage Portfolio in Czech Republic to Build on MLPE Success

Jul 8, 2025

Liberty Energy Inc. Announces Date Change for its Second Quarter 2025 Earnings Release and Conference Call

Jul 8, 2025

Murata Launches World’s First High-Frequency Filter Using XBAR Technology for 5G, Wi-Fi 7, and Future 6G...

Jul 8, 2025

Faraday Future Announces the Launch of the Early Reservation Portal for Faraday X (FX) Official FX Super One...

Jul 8, 2025

Luxfer Declares Quarterly Dividend

Jul 8, 2025

IDEX Corporation to Webcast Second Quarter 2025 Earnings Call

Jul 8, 2025

Avolon Announces Pricing of US$650 Million Senior Unsecured Notes Offering

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia